norvaline has been researched along with ng-nitroarginine methyl ester in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acchiardo, SR; Chiang, TM; Ford, K; Grokulsky, G; Kang, ES; Wang, YB | 1 |
| Gudyrev, OS; Gureev, VV; Korokin, MV; Korokina, LV; Kudryavtsev, KV; Pokrovskaya, TG; Pokrovskii, MV; Povetkin, SV | 1 |
2 other study(ies) available for norvaline and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Normal circulating adult human red blood cells contain inactive NOS proteins.
Topics: Arginase; Arginine; Chromatography, Thin Layer; Citrulline; Enzyme Inhibitors; Erythrocytes; Humans; Hydrolysis; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Valine | 2000 |
Study of Endothelial Protective Activity of Phenol-Derived Thrombin and Arginase-2 Inhibitors KUD-259 and KUD-974.
Topics: Animals; Arginase; Endothelium, Vascular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenol; Rats; Rats, Wistar; Signal Transduction; Thrombin; Valine | 2017 |